Oxycodone hydrochloride 10 mg and 20 mg: Supply issue

Supply issue Active

The supplier of oxycodone hydrochloride controlled-release tablets has advised that they are experiencing supply constraints impacting the 20 mg strength.

5 August 2021 Update

10 mg Oxycodone Sandoz has been resupplied. We anticipate the 20 mg Oxycodone Sandoz will be resupplied by the end of September.

Alternative product available

We have listed the OxyContin brand of oxycodone (10 mg and 20 mg tablets) to help cover this supply issue. A small volume of this product is being air freighted from Australia. This product is Medsafe approved. However, it does not quite meet labelling requirements. 

It does not have the following statements:

  • Controlled Drug B3
  • Directions for Use: 1 tablet to be taken every 12 hours or as directed by physician

Oxycontin Tab controlled-release

  • 10 mg (Pharmacode 2613824) $11.50 per 28
  • 20 mg (Pharmacode 2613832) $13.25 per 28

We are working with the supplier to understand re-supply timeframes.  

Affected products:

Tab controlled-release 10 mg | Oxycodone Sandoz  | 2559722 | $2.15 per 20(external link)

Tab controlled-release 20 mg | Oxycodone Sandoz  | 2559730 | $2.15 per 20(external link)

Alternative products listed

We have listed Sandoz's alternative products to ensure continuity of supply. These are available in a variety of pack sizes that are listed on the Pharmaceutical Schedule.

Check the Schedule listing for oxycodone(external link)

These alternative products are not Medsafe approved, as such they need to be supplied under section 29 of the Medicines Act.

Prescribing and supplying a medicine under section 29

Section 29 of the Medicines Act allows for medicines that are not Medsafe approved to be prescribed and supplied to people. The medicine must be prescribed by someone registered with the Medical Council of New Zealand – eg doctors. 

We know a section 29 medicine is not ideal. In this case, however, the alternative would be for patients to have no oxycodone in these strengths. 

We apologise for any inconvenience this causes. 

Read more about supplying medicines under section 29 – Medsafe website(external link)

Information for people taking medicine about what section 29 means – Health Navigator website(external link)

Who to contact

If you have any questions about this supply issue, please contact Sandoz:

If you have any questions about funding of these medicines, contact enquiry@pharmac.govt.nz